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Abstract  109 
Objective.  110 
Randomised controlled trials are required to address causality 111 
in the reported associations between maternal influences and 112 
offspring adiposity. The aim of this study was to determine 113 
whether an antenatal lifestyle intervention in obese pregnant 114 
women associated with improved maternal diet and reduced 115 
gestational weight gain leads to a reduction in infant adiposity 116 
and sustained improvements in maternal lifestyle behaviours 117 
at 6 months postpartum.   118 
Subjects and Methods.  119 
We conducted a planned postnatal follow up of a randomised 120 
controlled trial (UPBEAT) of a complex behavioural 121 
intervention targeting maternal diet (glycemic load and 122 
saturated fat intake) and physical activity in 1555 obese 123 
pregnant women. The main outcome measure was infant 124 
adiposity, assessed by subscapular and triceps skinfold 125 
thicknesses. Maternal diet and physical activity, indices of the 126 
familial lifestyle environment, were assessed by questionnaire.  127 
Results.  128 
698 (45.9%) infants (342 intervention, 356 standard antenatal 129 
care) were followed up at mean age 5.92 months. There was 130 
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no difference in triceps skinfold thickness z-scores between 131 
the intervention vs. standard care arms (difference -0.14 SD, 132 
95% CI -0.38 to 0.10, p=0.246), but subscapular skinfold 133 
thickness z-score was 0.26 SD (-0.49 to -0.02; p=0.03) lower in 134 
the intervention arm. Maternal dietary glycemic load (-35.34; -135 
48.0 to -22.67; p<0.001) and saturated fat intake (-1.93% 136 
energy; -2.64 to -1.22; p<0.001) were reduced in the 137 
intervention arm at 6 months postpartum. Causal mediation 138 
analysis suggested that lower infant subscapular skinfold 139 
thickness was mediated by changes in antenatal maternal diet 140 
and gestational weight gain rather than postnatal diet. 141 
 142 
Conclusion. 143 
This study provides evidence from follow-up of a randomised 144 
controlled trial that a maternal behavioural intervention in 145 
obese pregnant women has the potential to reduce infant 146 
adiposity and to produce a sustained improvement in 147 
maternal diet at 6 months postpartum. 148 
  149 
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Introduction  150 
The high prevalence of childhood obesity is a major health 151 
concern, with 27.3% of children estimated to be overweight or 152 
obese in the USA1. A combination of antenatal and postnatal 153 
exposures including environmental factors have been 154 
implicated in the development of childhood obesity2,3, which 155 
has been shown to track into adulthood1. Observational 156 
studies suggest that manipulation of maternal metabolism 157 
through diet and/or physical activity in the antenatal period 158 
has the potential to reduce childhood obesity2,4 and this has 159 
been unequivocally achieved in pregnant obese experimental 160 
animals and their offspring5. These observations have led to a  161 
consensus  that obesity is in part ‘programmed’ in-utero, in 162 
keeping with the ‘developmental programming’ hypothesis5. 163 
Recent analyses using Mendelian randomisation methods have 164 
provided evidence for a causal relationship between maternal 165 
pregnancy body mass index (BMI) and glucose with birth 166 
weight6, but any lasting causal effect on later infant adiposity 167 
is unknown. Well-designed randomized controlled trials in 168 
pregnant women and their offspring are required to infer 169 
causality through minimising selection bias and confounding5,7.  170 
 171 
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We undertook an RCT, the UK Pregnancies Better Eating and 172 
Activity Trial (UPBEAT) of a dietary and physical activity 173 
intervention in 1555 obese pregnant women8. Women were 174 
randomised to standard antenatal care or standard antenatal 175 
care with an intense behavioural intervention that focussed on 176 
improving insulin sensitivity through reducing dietary glycemic 177 
load and saturated fat intake8. Although the intervention did 178 
not reduce gestational diabetes (GDM) or large for gestational 179 
age delivery, the primary outcomes, there were significant 180 
improvements  in maternal antenatal diet (maternal glycaemic 181 
load/day at 28 weeks’ gestation,  mean difference -21, SD -26 182 
to -16, p=<0.0001), a reduction in maternal anthropometric 183 
measures of body fat assessed by sum of skinfold thicknesses 184 
(-3.2mm, -5.6 to -0.8, p=0.008) , lower total gestational weight 185 
gain (GWG) (-0.55kg, -1.08 to -0.02, p=0.041), and a modest 186 
improvement in physical activity at 28 weeks’ gestation (295 187 
min/week, 108 to 485, p=0.0015)8, all of which have been 188 
implicated in childhood obesity. 189 
 190 
To examine the hypothesis that the lifestyle intervention 191 
might reduce the influence of maternal obesity on offspring 192 
adiposity, our principal aim was to assess whether the UPBEAT 193 
intervention was associated with a reduction in measures of 194 
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childhood adiposity at 6 months of age, a pre-defined 195 
hypothesis within the trial protocol9. We also examined 196 
whether the pregnancy intervention had lasting effects on 197 
maternal diet and physical activity, and on known postnatal 198 
determinants of infant adiposity, including breastfeeding.  199 
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Patients and Methods 200 
Study design and setting  201 
Between July 2010 and May 2015, we conducted a planned 202 
follow up at 6 months postpartum of mothers and their 203 
offspring who had participated in the UPBEAT RCT in eight 204 
inner-city NHS Trust Hospitals in the UK. The study design and 205 
protocol9 were approved by the NHS Research Ethics 206 
Committee (UK Integrated Research Application System; 207 
reference 09/H0802/5).  208 
 209 
Participants and consent 210 
1555 women were recruited to the UPBEAT trial (≥16 years of 211 
age; pre-pregnancy BMI ≥30 kg/m2). Exclusion criteria included 212 
pre-existing disease and multiple pregnancy9. Following 213 
informed consent for themselves and follow up of their infants 214 
at 6 months postpartum, the participants were randomised to 215 
the intervention or standard antenatal care at 15+0-18+6 weeks’ 216 
gestation. For the purposes of this follow up study, women 217 
(but not their children), were excluded if pregnant at 6 months 218 
postpartum. If a participant had withdrawn from the trial but 219 
was willing to take part (n=2), written consent was obtained at 220 
the 6 month visit. Infants were excluded if aged <4 months or 221 
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>8 months of age at this visit. Comparison of demographic 222 
details at trial entry was made between women who declined 223 
to participate and those who took part. 224 
 225 
Outcomes 226 
Infant anthropometry 227 
The principal outcome of interest was infant adiposity 228 
assessed by measurement of infant skinfold thicknesses 229 
(triceps and subscapular, measured in triplicate by trained 230 
research staff using infant skinfold callipers). Subsidiary infant 231 
outcomes of infant adiposity included sum of skinfold 232 
thickness (calculated by addition), estimated total body fat 233 
(calculated by applying validated equations specific for infant 234 
sex10), weight (using a calibrated scale9), abdominal and upper 235 
mid-arm circumferences. For these measures, when reference 236 
World Health Organization population data were available, z-237 
scores were calculated11, including adjustment for infant age, 238 
sex and length. These standards are applicable to infant 239 
growth regardless of ethnicity, socioeconomic status and 240 
mode of feeding11. Z-scores were calculated for infant 241 
subscapular, triceps skinfold thickness, weight, BMI and arm 242 
circumference but not for sum of skinfold thicknesses. 243 
Occipitofrontal circumference, and crown-rump length and 244 
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crown-heel length obtained with a calibrated infantometer, 245 
were also measured.   246 
 247 
Duration of breastfeeding, weaning history, measures of 248 
appetite, infant sleeping patterns, physical activity,healthcare 249 
resource use and childcare9 were pre-specified outcomes. 250 
These were evaluated using the Infant Feeding and Growth 251 
Questionnaire12, the Child Eating and Behaviour 252 
Questionnaire13, the BISQ (Brief Infant Sleep Questionnaire)14, 253 
the Infant Behaviour Questionnaire (for child physical 254 
activity)15 and questionnaires ascertaining infant health, 255 
medical resource use and early care and education, 256 
respectively.  257 
 258 
Maternal dietary and physical activity analysis 259 
Maternal diet at 6 months postpartum was assessed using the 260 
same semi-quantitative food frequency questionnaire (FFQ) 261 
and analysed as previously reported for the mothers during 262 
their pregnancy8. Data was analysed only in questionnaires 263 
which were fully completed for both maternal diet and 264 
physical activity. Those with incomplete/missing dietary data 265 
were excluded (65.8%). There was no missing physical activity 266 
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data. The main outcomes of interest were maternal dietary 267 
glycaemic load, saturated fat intake and energy intake. Other 268 
outcomes included glycaemic index (GI), glycaemic load (GL), 269 
protein and fibre intake. Physical Activity was assessed, as it 270 
had been in pregnancy, using the International Physical 271 
Activity Questionnaire (IPAQ) and summarised as metabolic 272 
equivalents (METs) of energy expenditure16. 273 
 274 
Statistical analyses  275 
A complete-case analysis was undertaken for all participating 276 
mothers and infants.Treatment effects for continuous 277 
outcomes were expressed as differences in means obtained 278 
from multivariable linear regression, and binary endpoints as 279 
risk ratios with 95% confidence intervals (95%CI) obtained 280 
using binomial regression. For both we adjusted for 281 
minimisation variables (maternal BMI at trial enrolment, parity 282 
and ethnicity) and infant sex and age at follow up. We 283 
evaluated the number of intervention contact sessions during 284 
pregnancy on measures of infant adiposity.  285 
Although loss to follow-up was similar in both of the trial arms, 286 
we assessed the possibility that loss to follow-up resulted in 287 
selection bias using three complementary methods (further 288 
details in Supplementary Text 1). All sets of analyses were pre-289 
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planned sensitivity analyses. First, we used Little’s chi-squared 290 
covariate-dependent missing (CDM) test to explore evidence 291 
of data being missing not at random (MNAR), i.e. examining 292 
the possibility that in those who were lost to follow-up the 293 
effect of the intervention on outcomes differed from those 294 
who did attend the follow-up17. This was done for both 295 
offspring and maternal outcomes. Second, for the primary 296 
offspring outcomes only (subscapular and triceps skinfold 297 
thicknesses), we generated several simulation datasets, over a 298 
range of scenarios regarding missing data in both arms of the 299 
study that were informed by predictors of loss to follow-up 300 
(maternal BMI, parity and ethnicity)18. The scenarios selected 301 
aimed to cover a range of plausible situations that could result 302 
in bias under the assumption of data being missing at random 303 
(MAR). Thirdly, for the primary infant outcomes we used 304 
multivariate imputation chained equations to impute missing 305 
data for infant adiposity. Data were imputed to create 50 306 
datasets using 10 burn-in iterations for live-born infants using 307 
the following in the multivariate equations: maternal trial 308 
entry BMI, age, ethnicity, parity, early pregnancy smoking 309 
status, randomisation allocation, measures of maternal 310 
anthropometry including GWG, maternal diet and physical 311 
activity at 27-28+6, 34+0-36+0 weeks’ and 6 months postpartum 312 
(glycaemic load, glycaemic index, saturated fat, carbohydrate, 313 
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protein, energy intake), gestation at delivery, infant sex, age at 314 
follow up, mode and duration of early feeding, sleep, child 315 
health and infant inpatient admissions. The multivariate 316 
imputations assume MAR and can also increase statistical 317 
power and so allow us to explore whether loss to follow-up 318 
might have resulted in type-2 statistical errors. Full details of 319 
all of these sensitivity analyses are provided in Supplementary 320 
Text 1. Analyses were performed using Stata version 14.0.  321 
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Results  322 
Participants 323 
Of the 1555 participants randomised to UPBEAT at 15+0-18+6 324 
week’s gestation between July 2010 and May 2015 and with a 325 
live born infant, 1522 were approached at this time. Of these 326 
1522, 720 (47.3%) infants and 707 (46.5%)mothers took part in 327 
this study. Thirteen mothers were excluded as they were 328 
pregnant at time of study, and 22 infants were excluded 329 
because the follow up appointment was held ≤4 months or ≥8 330 
months postpartum (Figure 1). In comparsion to those who did 331 
not take part, mothers who attended the 6month visit were on 332 
average 1.3 years older, more likely to be Caucasian, 333 
nulliparous, to have had GDM in the index pregnancy(28.2% 334 
vs. 23.3%; p=0.041), and were less likely to be current smokers 335 
(Supplementary Table 1a, Supplementary Text 1). There were 336 
no differences in maternal early pregnancy BMI and sum of 337 
skinfold thicknesses between women who participated in the 338 
6 month follow-up visit compared to those who did not. 339 
Women in the intervention arm demonstrated reduced GWG 340 
as previously reported8. The infants who attended the 6 341 
month appointmenthad a longer gestational age at delivery 342 
(by 2 days), were 67g heavier, and more likely to have been 343 
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breastfed at birth than those that did not attend 344 
(Supplementary Table 1b). 345 
 346 
There was no difference between mean maternal BMI 347 
between the intervention and standard care groups at trial 348 
entry (36.17 vs. 36.31 kg/m2, respectively) or at 6 months 349 
postpartum (36.26 vs. 36.45 kg/m2, respectively). The 350 
incidence of maternal smoking at 15+0-18+6 weeks’ gestation 351 
was higher in the standard antenatal care arm in comparison 352 
to the intervention arm (5.6% vs. 2.0%)(Table 1). There were 353 
no differences in all other demographic and clinical variables 354 
between the two study arms (Table 1). 355 
 356 
Infant anthropometry 357 
Three hundred and fifty six infants in the standard antenatal 358 
care arm and 342 infants in the intervention arm (mean age 359 
5.82 months) had anthropometric measurements at age 6 360 
months. There was no statistical difference in triceps skinfold 361 
thickness in the intervention vs. the standard care arm 362 
(difference -0.14 SD, 95% CI -0.38 to 0.10), p=0.246), but 363 
subscapular skinfold thickness z-score was -0.26 SD (-0.49 to -364 
0.02; p=0.031) lower in the intervention arm (Table 2). Infants 365 
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in the intervention arm had a 5% lower subscapular skinfold 366 
thickness  (-0.38mm; -0.70 to -0.06; p=0.021), compared to 367 
infants in the standard antenatal care arm (Table 2). The infant 368 
sum of skinfold thickness was 0.63mm lower in the 369 
intervention arm, but did not reach statistical significance 370 
(p=0.058) in comparsion to the standard antenatal care arm 371 
(Table 2). There were no differences in BMI z-score and 372 
abdominal circumference (Table 2) or in other anthropometric 373 
measures between the two arms(Supplementary Table 2).  374 
Maternal smoking status at trial entry did not influence the 375 
difference in subscapular skinfold thickness between the two 376 
arms (Supplementary Table 3). Undertaking sensitivity 377 
analyses for deviation from the missing at random assumption, 378 
significant differences in infant subscapular skinfold thickness 379 
(mm) were found within a range of -0.35 to -0.38mm 380 
dependent on the assumption of missinginess taken 381 
(Supplementary Text 1  and Supplementary Table 4). Similar 382 
results to the complete-case analysis were also observed for 383 
infant triceps skinfold thickness (Supplementary Table 5). 384 
 385 
There was no difference in infant feeding between the two 386 
trial arms, nor appetite and satiety responsiveness and infant 387 
childcare. Infants were exclusively breastfed, on average for 388 
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82.7 (SD 65.3) days and total number of hours spent sleeping 389 
were similar between arms (Supplementary Table 7). There 390 
was an increase in infant inpatient nights in the intervention 391 
arm, attributable to 1 infant requiring long-term hospital 392 
admission due a ventricular septal defect repair 393 
(Supplementary Table 7). We observed no differences in infant 394 
use of medications  (Supplementary Table 6) or in cause of 395 
hospital inpatient admissions, exect for gastrointestinal 396 
related disorders, which were lower in the intervention arm 397 
(Supplementary Table 8). There was no association between 398 
the number of antenatal contact sessions with the health 399 
trainer and measures of infant anthropometry (Supplementary 400 
Table 9). 401 
No interactions were observed between randomisation 402 
allocation and infant sex (Supplementary Table 10), but there 403 
was a significant interaction of breast feeding (< 3mths/ 404 
≥3mths) with the intervention; triceps skin fold thickness was 405 
lower in infants of mothers in the intervention arm who 406 
breastfed ≥3 months vs those in the standard care arm -407 
0.90mm (-1.59 to -0.21); p=0.011; Wald interaction test; 408 
p=0.016) (Figure 3). Similar patterns of differences of effect by 409 
breastfeeding for sum of skinfold thicknesses, estimated total 410 
body fat and arm circumference did not achieve statistical 411 
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significance (p-values for interactions all ≥ 0.05) 412 
(Supplementary Table 11).   413 
 414 
Maternal diet and physical activity 415 
In those women who provided complete dietary data GI, GL, 416 
saturated fat and total energy intake were reduced in the 417 
mothers in the intervention arm in comparison to standard 418 
care, as well as a significant reduction in total fat and protein 419 
intakes (Figure 2 & Table 3). When the under-reporters 420 
(calorie intake) were included in sensitivity analyses, there 421 
were no differences in the effect size estimates of dietary 422 
variables. Furthermore we found no difference in maternal 423 
characteristics (including maternal age, BMI and 424 
socioeconomic deprivation status) between those under-425 
reporting and those not under-reporting calorie intake. There 426 
was no effect of the intervention on maternal physical activity 427 
(Table 3). 428 
 429 
Causal analysis suggested  direct effects of the intervention 430 
associated reduction in maternal early GWG (between 15-18+6 431 
and 27-28+6 weeks’ gestation) (p=0.015), late GWG (between 432 
27-28+6 and 34-36 weeks’ gestation)  (p=0.009), total GWG 433 
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(p=0.014) and maternal dietary saturated fat intake at 27-28+6 434 
week’s gestation (p=0.016) in relation to infant subscapular 435 
skinfold thickness at age 6 months (Supplementary Figure 1). 436 
In contrast, there was no suggested effect of postnatal 437 
maternal diet on the observed differences in infant 438 
subscapular skinfold measurements (Supplementary Figure 2). 439 
As there was no effect of the intervention on maternal 440 
physical activity, there was no rationale for exploring a causal 441 
mediating impact of maternal physical activity on offspring 442 
adiposity. 443 
  444 
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Discussion 445 
This study has addressed the effect of a pregnancy lifestyle 446 
behavioural intervention in obese women on offspring 447 
adiposity and maternal diet and physical activity at 6 months 448 
postpartum. We have found, to our knowledge for the first 449 
time, that a dietary and physical activity intervention in 450 
pregnant women with obesity was associated with a reduction 451 
in a measure of offspring adiposity, and that changes in 452 
maternal diet during pregnancy persisted into the postnatal 453 
period. Further analyses suggested that the effect of the 454 
intervention on offspring adiposity was independently 455 
mediated by the observed reduction in maternal gestational 456 
weight gain, dietary fat and energy intake in pregnancy and 457 
therefore an expectation that lifestyle interventions have the 458 
potential to reduce offspring adiposity. Subscapular skinfold 459 
thickness, in comparison to the other anthropometric 460 
measurements assessed, is recognised as an accurate index of 461 
central adiposity, with a generally lower measurement error 462 
than triceps skinfold thickness19,20. In children and adults, 463 
subscapular skinfold thickness has been related to impaired 464 
glucose metabolism, and in adolescents to increased serum 465 
cholesterol concentration21, 22. It is plausible, therefore that 466 
the maternal dietary and weight changes resulting from the 467 
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intervention may influence infant body composition towards a 468 
healthier metabolic profile22-24.  469 
 470 
Although the magnitude of difference in this measure of 471 
adiposity (subscapular skinfold thickness) between 472 
intervention and controls arms was modest (5%), it reflected a 473 
0.26 reduction in z-score, which incorporated adjustment for 474 
infant sex, age and length to allow comparisons to a reference 475 
population. Indications from mother-child cohorts, including 476 
the USA Project Viva study, suggest that even modest 477 
differences in body composition  at age 6 months may be 478 
amplified as the child grows older, and that this may be 479 
apparent as early as 3 years25. The Bogalusa Heart Study 480 
observed that greater offspring childhood subscapular skinfold 481 
thickness related to parental type 2 diabetes was associated 482 
with a subsequent adverse metabolic profile in early 483 
adulthood22. Any persistent influence of the intervention on 484 
childhood obesity will only be revealed as the children grow 485 
up, but an abundance of evidence suggests that increased 486 
adiposity tracks from infancy, through childhood to 487 
adulthood1. 488 
 489 
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We are aware of only two relevant similar studies. The first, 490 
the Lifestyle in Pregnancy study (LIP)26, assessed body 491 
composition in older infants (2.8 years) of obese 492 
mothers(n=157) who had been randomised to an antenatal 493 
lifestyle intervention with the primary aim of reducing 494 
gestational weight gain. No change in infant total fat mass, as 495 
assessed by DEXA scan, was observed27. However, it was not 496 
reported whether this intervention modified specific 497 
components of maternal antenatal diet or body composition, 498 
although a reduction in median gestational weight gain was 499 
observed. Secondly, a recent RCT of a low glycaemic diet, but 500 
in women of heterogenous BMI, despite a difference in 501 
reduction of thigh circumference found no difference in infant 502 
body composition at 6 months of age between intervention 503 
and control arms28, 29. The difference between these studies 504 
and UPBEAT may relate to the greater intensity of the UPBEAT 505 
intervention, involving 8 contact sessions with health trainers, 506 
at weekly intervals 8. 507 
 508 
There remains a paucity of data regarding the long-term 509 
efficacy of lifestyle interventions in obese pregnant women5. 510 
Our study has shown that dietary advice focussing on 511 
reduction of maternal insulin resistance, as a component of a 512 
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complex intervention, can have a prolonged effect which may 513 
have potential to improve long term health as well as familial 514 
nutritional environment12, 30, 31. We did not, however, find any 515 
differences between groups in maternal BMI or measures of 516 
adiposity at 6 months postpartum. A sustained effect of any 517 
maternal dietary intervention on maternal dietary intake 518 
postpartum has to our knowledge not been reported 519 
previously. In contrast, in the LIMIT trial, follow up of 50.5% of 520 
participants, reported no difference in maternal dietary 521 
composition at 4 months postpartum32, also by self-report. 522 
The lower magnitude of intervention effects on maternal 523 
dietary variables compared with UPBEAT may explain these 524 
differences. 525 
 526 
Using the method of causal mediation analysis, we found 527 
evidence that the lower dietary saturated fat and energy 528 
intake at 28 weeks’ gestation induced by the UPBEAT 529 
intervention, rather than the change in glycemic load, was 530 
associated with the reduction in infant subscapular skinfold 531 
thickness at 6 months of age. The reduction in gestational 532 
weight gain irrespective of timing and total gestational weight 533 
gainwere also directly associated with the observed 534 
difference. These observations would concur with several 535 
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reports describing associations between maternal gestational 536 
weight gain or diet and offspring adiposity4, 33, 34. Antenatal 537 
interventions shown to improve maternal diet and 538 
subsequently reduce GWG may therefore be pragmatic and 539 
effective measures to reduce early infant adiposity. 540 
 541 
The observation that exclusive breastfeeding for more than 3 542 
months may interact with the maternal intervention to reduce  543 
offspring triceps skinfold thickness provides some evidence 544 
that breast feeding may compound the benefits of the 545 
maternal intervention, although caution should be exercised in 546 
over-interpretation as the study was not powered to test 547 
interactions such as these. The role of other intrauterine 548 
exposures remains to be elucidated; whilst we previously 549 
reported no differences in fasting lipids, c-peptide and insulin 550 
at 28 weeks’ gestation between randomisation arms8, ongoing 551 
biochemical and metabolomic analyses in maternal and cord 552 
blood may provide insight into mechanistic pathways.  553 
 554 
A limitation of our study was the follow up of only 47.3% of 555 
those infants eligible from the original RCT8, but this was 556 
similar to the rate of follow up of recently published RCTs in 557 
pregnant women27, 28, 35. Due to the stringent inclusion of only 558 
28 
 
complete dietary questionnaires, maternal dietary data was 559 
calculated only for 34.2% of the mothers. The dietary data was 560 
by self report but compared favourably to a more rigorous 561 
method (triple pass 24hr recall) as assessed in the pilot trial36. 562 
Strengths of the study include the prospective collection of in-563 
depth data addressing familial and individual determinants of 564 
infant adiposity, and of maternal in-utero exposures. The 565 
richness of data in the UPBEAT study can be considered both a 566 
strength and limitation. Whilst providing comprehensive 567 
information relevant to developmental origins of early infant 568 
obesity, and assessment of mediation effects, limits are 569 
imposed on interpretation of secondary analyses in the 570 
context of multiple testing. 571 
 572 
In conclusion, this study provides evidence of the potential for 573 
targeted intervention in obese women to improve health for 574 
the mother and her offspring. Pregnancy, as demonstrated in 575 
this study, appears to be a pragmatic ‘teachable’ moment for 576 
initiating long-term healthier dietary behaviours in the mother 577 
and reducing a physiologically relevant measure of adiposity in 578 
the offspring.  579 
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Figure Legends 788 
Figure 1.Consort diagram of participants enrolled in the UPBEAT 789 
trial at 6 months postpartum 790 
Figure 2.Maternal Glycaemic load (a), Saturated fat (b) and Energy 791 
intake (c) at 6 months postpartum by randomisation allocation. 792 
Abbreviations: %E- Percentage energy; kcal/day- kilocalorie per day. 793 
Arithmetic mean with standard error plotted at each gestation (weeks), 794 
showing nutritional consumption per day.  795 
 796 
Figure 3. Relationship between duration of exclusive breast 797 
feeding and anthropometry measured at 6 months postpartum in 798 
698 infants from the UPBEAT trial. 799 
Effect estimates/ mean differences plotted with 95% confidence intervals.  800 
For triceps skinfold thickness (n=627), sum of skinfold thickness (n=547), 801 
total body fat (n=547) and upper mid-arm circumference (n=676). 802 
*Significant Wald test for interaction p<0.05 803 
 804 
 805 
 806 
Figure 1.  
1555 obese pregnant women randomised 
772 (49.6%) allocated to standard antenatal care 783 (50.3%) allocated to UPBEAT intervention
757 (98.1%) infants with known birthweight  
     2 lost to follow up 
     3 withdrew permission to use data  
     2 miscarriage  
     4 fetal death in utero  
     3 terminations  
1 excluded after trial 
enrolment 
765 (97.7%) infants with known birthweight  
     6 lost to follow up 
     3 withdrew permission to use data  
     6 miscarriage  
     2 fetal death in utero  
     1 termination  
365 (48.2%) infants followed up at 6 months  
       344 not responded to follow up contact 
       48 refused follow up  
        
355 (46.5%) infants with known birthweight  
       357 not responded to follow up  
       52 refused follow up   
       1 cot death at 2.5 months  
356 (47.0%) principal infant outcomes at 6 months  
9 infants excluded as age ≤ 4 months or ≥8 
months 
342 (44.7%) infant outcomes at 6 months  
13 infants excluded as age ≤ 4 months or ≥8 
months
Consort diagram of participants enrolled in the UPBEAT trial at 6 months postpartum 
 
Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maternal Glycaemic load (a), Saturated fat (b) and Energy intake (c) at 6 months postpartum by 
randomisation allocation. 
Abbreviations: %E- Percentage energy; kcal/day- kilocalorie per day 
Arithmetic mean with standard error plotted at each gestation (weeks), showing nutritional consumption per 
day. *p<0.01. 
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Relationship between duration of exclusive breast feeding and anthropometry measured at 6 
months postpartum in 698 infants from the UPBEAT trial.  
For triceps skinfold thickness (n=627), sum of skinfold thickness (n=547), Total body fat (n=547) and upper 
mid-arm circumference (n=676).  
*Significant Wald test for interaction p<0.05 
 
-1.5 -1 0 1-0.5 0.5-2
Triceps Skinfold Thickness (mm)*
-3 -2 -1 0 1-4 2
Total Body Fat (%)
-3 -2 -1 0 1
Sum Of Skinfold Thickness (mm)
-1 0-0.5 0.5 1
Upper Mid-Arm Circumference (cm)
                Exclusive breastfeeding ≥ 3months                              Exclusive breastfeeding <3months    
Table 1.  
   Intervention (n=342)  Control (n= 356) 
   Mean (SD)/N(%)  Mean (SD)/N(%) 
Maternal demographics    
Pre-pregnancy       
Maternal age (years)  N=342 31.30 (5.04) N=356 31.00 (5.58) 
Maternal ethnicity Asian N=342 14 (4.1) N=356 11 (3.1) 
 Black  62 (18.1)  72 (20.2) 
 Other  19 (5.6)  22 (6.2) 
 White   247 (72.2) 251 (70.5)
Multiparous  N=342 169 (49.4) N=356 174 (48.9) 
Index of multiple deprivation 
quintiles* 
1 (least deprived) N=341 15 (4.4) N=355 19 (5.4) 
 2  29 (8.5) 19 (5.4) 
 3  35 (10.3)  38 (10.7) 
 4  119 (34.9) 136 (38.3)
 5 (most deprived)  143 (41.9) 143 (40.3)
Family history GDM N=333 10 (3.0) N=344 11 (3.2) 
 PET N=333 40 (12.0) N=344 33 (9.6) 
 T2DM N=341 86 (25.2) N=356 70 (19.7) 
15-18 weeks’ gestation       
Current smoker^   N=342 7 (2.0) N=356 20 (5.6) 
Maternal anthropometry 
Maternal BMI 
(kg/m2) 
N=342 36.17 (4.98) N=356 36.31 (4.69)
Systolic blood 
pressure (mmHg) 
N=340 117.90 (11.15) N=352 119.32 (11.00) 
Sum of skin folds 
(cm)ⱡ  
N=337 124.34 (28.46) N=354 122.18 (25.06) 
Maternal Antenatal and postpartum  history     
Gestational diabetes **  N=336 97 (28.9) N=346 93 (26.9) 
Pre-eclampsia∞   N=340 11 (3.2) N=353 11 (3.1) 
Total gestational weight gain 
from pre-pregnancy weight¶ 
 N=320 6.92 (4.65) N=332 7.83 (4.41) 
Maternal 6 month 
postpartum BMI (kg/m2) 
 N=345 36.26 (5.14) N=355 36.45 (5.41) 
Change in maternal weight 
from 15-18 weeks to 6 
months postpartum (kg) 
 N=344 -0.37 (7.41) N=355 0.36 (6.71)
Infant demographics     
Infant age at 6 months 
follow up (months) 
 N=342 5.80 (0.65) N=356 5.85 (0.72)
Gestation at birth (weeks)  N=342 39.73 (1.54) N=356 39.55 (2.29) 
Birthweight (gm)  N=342 3479.23 (529.40) N=356 3436.55 (604.09) 
Large for Gestational Age 
>90th (customised)†  
 N=342 30 (8.8) N=356 27 (7.6) 
Neonatal feeding history at 
72 hrs 
Artificial feeding N=341 63 (18.5) N=354 78 (22.0) 
Breast feeding N=341 213 (62.5) N=354 216 (61.0) 
Partially 
breastfeeding 
N=341 65 (19.1) N=354 132 (37.1) 
 
Maternal and Infant demographics by randomisation allocation at 6 month postpartum visit. 
^ Maternal current smoking at 15-18 weeks’ gestation significantly different between intervention and control 
groups(p=0.02).*IMD quintiles are calculated for the region of residence, by fifths of the population. UK wide-
scores were developed by reconciling Scottish data to English norms. ** Gestational diabetes diagnosis by 
International Association of Diabetes in Pregnancy Study Group criteria at 27+0 to 28+6 weeks’ gestation.  
ⱡ Calculated by the addition of biceps, triceps, suprailiac and subscapular skinfold measurements each 
measured in triplicate. ∞ Pre-eclampsia defined as systolic blood pressure ≥140 mm Hg, diastolic blood 
pressure ≥90 mm Hg, or both, on at least two occasions 4 hours apart, with proteinuria ≥300 mg/ 24 hours. 
¶Gestational weight gain calculated using estimated weight before pregnancy according to the Institute of 
Medicine Weight Management in Pregnancy Guidelines. † Customised birthweight cenƟle calculated adjusƟng 
for maternal height and weight, ethnic origin, parity and sex of the infant.  
 
 
Table 2. 
 
Infant anthropometry by randomisation allocation at 6 months postpartum visit 
*Treatment effect adjusted for minimisation variables of randomisation (maternal BMI, ethnicity and parity), 
infant age at 6 month follow up and infant sex. **Z-scores calculated using WHO Anthro; version 3.2.2. 
 Intervention  Control Mean Diff/ Risk 
Ratio* (95% CI) 
p-
value Mean (SD) Mean (SD)
Subscapular skinfold 
thickness z-scores** 
N=267 0.08 (1.37) N=280 0.36 (1.37) -0.26 (-0.49 to -0.02) 0.031 
Subscapular skinfold 
thickness (mm) 
N=267 7.55 (1.86) N=281 7.95 (2.03) -0.38 (-0.70 to -0.06) 0.021 
Triceps skinfold 
thickness z-scores** 
N=296 0.10 (1.56) N=298 0.24 (1.43) -0.14 (-0.38 to 0.10) 0.246 
Triceps skinfold 
thickness (mm)∞ 
N=307 9.69 (2.76) N=320 9.87 (2.69) -0.22 (-0.64 to 0.20) 0.305 
Sum of skinfolds 
(mm) 
N=267 17.08 (3.93) N=280  17.71 (3.97) -0.63 (-1.30 to 0.04) 0.058 
BMI for age z-
scores**  
N=317 -0.07 (1.86) N=320 0.04 (1.78) -0.12 (-0.40 to 0.16) 0.393 
Abdominal 
circumference (cm) 
N=329 43.74 (4.73) N=347 43.72 (6.27) 0.07 (-0.78 to 0.92) 0.872 
 Table 3. 
  
Intervention Standard care 
Treatment effect* 
P-value 
Mean Difference (95% CI) 
Mean (SD)/ N (%) Mean (SD)/ N (%)
Maternal diet**   
Glycaemic Load 
per day 
N=116 98.94 (32.80) N=126 134.69 (62.68) -35.34 (-48.00 to -22.67) <0.001
Saturated fat (%E) N=116 11.89 (2.61) N=126 13.75 (2.85) -1.93 (-2.64 to -1.22) <0.001
Total energy 
(kcal/day) 
N=116 1473.84 (596.60) N=126 1831.21 (727.65) -354.52 (-505.95 to -203.10) <0.001
Glycaemic Index 
(0-100) 
N=116 53.06 (4.06) N=126 57.04 (3.74) -3.94 (-4.93 to -2.94) <0.001
Carbohydrate 
(%E) 
N=116 47.69 (6.71) N=126 48.03 (6.22) -0.18 (-1.84 to 1.49) 0.835
Total fat (%E) N=116 29.70 (4.94) N=126 32.26 (4.75) -2.65 (-3.91 to -1.38) <0.001
Protein (%E) N=116 22.57 (4.42) N=126 19.82 (3.94) 2.70 (1.63 to 3.77) <0.001
Fibre (g/day) N=116 12.12 (4.36) N=126 12.27 (6.81) -0.12 (-1.57 to 1.33) 0.873
Maternal physical 
activity^ 
 Median (IQR) Median (IQR) Median regression (95% CI) 
MET (min/week)† N=349 2190 (1053, 4158) N=358 2012 (990, 4088) 93.95 (-264.81 to 452.72) 0.607
MVPA (min/week) N=349 120 (0, 360) N=358 120 (0, 360) 10.43 (-39.31 to 60.18) 0.681
Walking 
(min/week) 
N=349 420 (180, 840) N=358 420 (180, 630) 0.00 (-68.88 to 68.88) 1.00
 
Maternal dietary and physical activity data by randomisation allocation at 6 months postpartum 
Abbreviations: CI- Confidence Intervals;  %E- %Energy; g/day- grams per day; kcal/day- kilocalories per day; 
MET- Metabolic equivalent of task; MVPA- Moderate and Vigorous physical activity.  
*Treatment effect adjusted for maternal trial entry BMI, parity and ethnicity. ** Maternal diet- Women with a 
reported energy ≤4.5 Mj/day or ≥20Mj/day at 15+0 -18+6 weeks’ gestation were excluded from the analyses of 
diet. Dietary intervention estimates were calculated using multiple regression and adjusted for maternal pre-
pregnancy current smoking status. ^ Physical activity estimates were calculated using bootstrapped (1000 
replications), median regression adjusting for maternal pre-pregnancy current smoking status. † MET is 
defined as the energy expenditure ratio of activity to rest; one MET is approximately equal to an individual’s 
resting energy expenditure. 
  
